AGSCX Mutual Fund

AGSCX Mutual Fund

NAV$8.18
See how much of AGSCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$12M
Expense Ratio
2.12%
Dividend Yield (Current)
-
Holdings
113
Inception Date
Jul 31, 1997
Fund Family
Alger
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+19.83%
1 Year+19.83%
3 Year+19.48%
5 Year-2.01%
10 Year+10.55%

Asset Allocation

Stocks: 92.13%
Cash: 6.46%
Other: 1.30%
See how much of AGSCX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
DTRXXDreyfus Trsy Oblig Cash Mgmt Cl Ins5.92%
FBRXForte Biosciences Inc4.78%
TPCTutor Perini Corp2.83%
VSCOVictoria'S Secret & Co Common Stock USD 0.012.62%
ADPTAdaptive Biotechnologies2.47%
Top 10 Concentration: 29.95%Report Date: Jul 31, 2026
Download all 113 holdings for AGSCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$0.07
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

AGSCX Mutual Fund Overview

AGSCX Mutual Fund (Alger Small Cap Growth Fund Class C) is managed by Alger with $11.7M in net assets. AGSCX expense ratio is 2.12%, holding 113 positions across sectors including Health Care, Industrials, Information Technology. Inception date: 1997-07-31.

AGSCX performance shows a YTD return of 19.83%. The 1-year return is 19.83% and the 5-year return is -2.01%.

AGSCX top holdings include Dreyfus Trsy Oblig Cash Mgmt Cl Ins (5.9%), Forte Biosciences Inc (4.8%), Tutor Perini Corp (2.8%), Victoria'S Secret & Co Common Stock USD 0.01 (2.6%), Adaptive Biotechnologies (2.5%). Go to all AGSCX holdings, AGSCX sectors, or AGSCX dividends.

AGSCX can be compared against other funds. Use AGSCX overlap to find shared positions, or AGSCX vs another fund for a side-by-side view. AGSCX alternatives are available via the screener, along with tax-loss harvesting opportunities.